Monopar Therapeutics Inc
NASDAQ:MNPR

Watchlist Manager
Monopar Therapeutics Inc Logo
Monopar Therapeutics Inc
NASDAQ:MNPR
Watchlist
Price: 74.605 USD -3.17% Market Closed
Market Cap: 498.4m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of MNPR.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MNPR Intrinsic Value
Not Available
Base Case Scenario
Compare MNPR to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MNPR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Monopar Therapeutics Inc

Current Assets 144.1m
Cash & Short-Term Investments 143.7m
Other Current Assets 414.8k
Non-Current Assets 106.7k
PP&E 106.7k
Current Liabilities 2.6m
Accounts Payable 2.5m
Accrued Liabilities 31.4k
Non-Current Liabilities 70.8k
Other Non-Current Liabilities 70.8k
Efficiency

Free Cash Flow Analysis
Monopar Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Monopar Therapeutics Inc

Revenue
0 USD
Operating Expenses
-21.6m USD
Operating Income
-21.6m USD
Other Expenses
2.2m USD
Net Income
-19.4m USD
Fundamental Scores

MNPR Profitability Score
Profitability Due Diligence

Monopar Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Monopar Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

MNPR Solvency Score
Solvency Due Diligence

Monopar Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Monopar Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MNPR Price Targets Summary
Monopar Therapeutics Inc

Wall Street analysts forecast MNPR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MNPR is 114.005 USD with a low forecast of 93.93 USD and a high forecast of 136.5 USD.

Lowest
Price Target
93.93 USD
26% Upside
Average
Price Target
114.005 USD
53% Upside
Highest
Price Target
136.5 USD
83% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Monopar Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MNPR is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MNPR Insider Trading
Buy and sell transactions by insiders